HK1222339A1 - 金屬-β-內酰胺酶的抑制劑 - Google Patents

金屬-β-內酰胺酶的抑制劑

Info

Publication number
HK1222339A1
HK1222339A1 HK16110616.5A HK16110616A HK1222339A1 HK 1222339 A1 HK1222339 A1 HK 1222339A1 HK 16110616 A HK16110616 A HK 16110616A HK 1222339 A1 HK1222339 A1 HK 1222339A1
Authority
HK
Hong Kong
Prior art keywords
metallo
lactamase
enzymes
inhibitors
Prior art date
Application number
HK16110616.5A
Other languages
English (en)
Inventor
Gerry Wright
Wenliang Wang
Andrew King
Original Assignee
Univ Mcmaster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcmaster filed Critical Univ Mcmaster
Publication of HK1222339A1 publication Critical patent/HK1222339A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HK16110616.5A 2013-05-07 2016-09-06 金屬-β-內酰胺酶的抑制劑 HK1222339A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361820277P 2013-05-07 2013-05-07
PCT/CA2014/050434 WO2014179885A1 (en) 2013-05-07 2014-05-07 INHIBITORS OF METALLO-ß-LACTAMASE-ENZYMES

Publications (1)

Publication Number Publication Date
HK1222339A1 true HK1222339A1 (zh) 2017-06-30

Family

ID=51866575

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16110616.5A HK1222339A1 (zh) 2013-05-07 2016-09-06 金屬-β-內酰胺酶的抑制劑

Country Status (8)

Country Link
US (2) US10016383B2 (zh)
EP (1) EP2994124A4 (zh)
JP (2) JP6356227B2 (zh)
KR (1) KR20160018530A (zh)
AU (1) AU2014262351B2 (zh)
CA (1) CA2910421A1 (zh)
HK (1) HK1222339A1 (zh)
WO (1) WO2014179885A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101798176B1 (ko) * 2014-12-16 2017-11-15 주식회사 엠디헬스케어 세균 유래의 나노소포체를 이용한 세균성 감염질환 원인균 동정방법
EP3085463A1 (en) * 2014-12-16 2016-10-26 Luxembourg Institute of Science and Technology (LIST) Method of degradation and inactivation of antibiotics in water by immobilized enzymes onto functionalized supports
JPWO2016175223A1 (ja) * 2015-04-28 2018-02-15 塩野義製薬株式会社 三環性化合物、およびそれらの使用
CN106518702B (zh) * 2015-09-10 2019-03-22 北京大学 曲霉明素a及其衍生物、合成方法与应用
WO2017070794A1 (en) * 2015-10-30 2017-05-04 Mcmaster University Process for the preparation of 2-[2-(2-amino-2-carboxy-ethylamino)-2-carboxy-ethylamino]-succinic acid (am-a) and analogs and derivatives thereof
CN105646251B (zh) * 2016-02-02 2017-12-15 厦门聚生元医药科技有限公司 一种曲马胺化合物及其合成方法
CN112592957B (zh) * 2020-12-16 2022-09-16 首都医科大学附属北京朝阳医院 一种cre菌株及其产酶类型的快速鉴别方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056941A (ja) * 1983-09-07 1985-04-02 Suntory Ltd ２−アミノ−３−ブテノ−ル誘導体
JPS62149616A (ja) * 1985-12-25 1987-07-03 Sankyo Co Ltd 感染防御能増強剤
JPH06192081A (ja) * 1992-12-25 1994-07-12 Sapporo Breweries Ltd エンドセリン変換酵素阻害剤及び高エンドセリン症治療剤
US20020061281A1 (en) 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6548492B1 (en) 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
ATE285770T1 (de) * 1999-10-29 2005-01-15 Merck & Co Inc Verfahren zur herstellung von carbapenem- antibiotika zubereitungen
US20050065141A1 (en) * 2003-07-31 2005-03-24 Odink Debra A. Carbapenems useful in treating and preventing pulmonary infections, pharmaceutical compositions thereof and modes of administration thereof
AU2003290394A1 (en) * 2003-09-30 2005-04-14 Lupin Ltd. Extended release formulation of beta-lactam antibiotics
JP5303771B2 (ja) * 2007-01-17 2013-10-02 独立行政法人産業技術総合研究所 抗生物質徐放機能を有する有機無機複合材料とその製造方法
JP5700915B2 (ja) * 2008-04-18 2015-04-15 栄研化学株式会社 黄色ブドウ球菌検出用培地

Also Published As

Publication number Publication date
WO2014179885A1 (en) 2014-11-13
US20180296517A1 (en) 2018-10-18
US10016383B2 (en) 2018-07-10
JP6356227B2 (ja) 2018-07-11
KR20160018530A (ko) 2016-02-17
AU2014262351A1 (en) 2016-01-07
AU2014262351B2 (en) 2019-05-30
US20160081960A1 (en) 2016-03-24
JP2016520582A (ja) 2016-07-14
EP2994124A1 (en) 2016-03-16
CA2910421A1 (en) 2014-11-13
JP2018154654A (ja) 2018-10-04
EP2994124A4 (en) 2017-01-18

Similar Documents

Publication Publication Date Title
IL279682A (en) Benzoquinolone compounds as VMAT2 inhibitors
HK1212691A1 (zh) 犬尿氨酸途徑的抑制劑
SI3080100T1 (sl) Inhibitorji lizin specifične demetilaze-1
IL265496A (en) bace1 inhibitors
HK1216531A1 (zh) 新的抑制劑
GB201314578D0 (en) Bicyclic inhibitors
HK1222339A1 (zh) 金屬-β-內酰胺酶的抑制劑
EP3632467C0 (en) INHIBITORS OF COMPLEMENT FACTOR H
HK1221645A1 (zh) 的苯並喹啉抑制劑
IL240763B (en) The halopyrazoles as thrombin inhibitors
HK1221159A1 (zh) 轉移抑制劑
EP2959896A4 (en) INHIBITOR OF PHOSPHORYLATION OF PROTEIN T
GB201312311D0 (en) Uses of enzyme inhibitors
GB201323021D0 (en) Use of kinase inhibitors
GB201321227D0 (en) Use of kinase inhibitors
GB201320835D0 (en) HIF inhibitors
GB201305503D0 (en) Inhibitor